Table 4 Associations of 25-hydroxyvitamin D3 and parathyroid hormone with blood pressure in antihypertensive medication users and non-users a)
Women (n= 90) | Â | BP medication users (n= 55) | BP medication non-users (n= 35) | ||
|---|---|---|---|---|---|
| Â | Â | SBP (mmHg) | DBP (mmHg) | SBP (mmHg) | DBP (mmHg) |
25(OH)D3 (nmol/L) | Model 1 | -0.119 | -0.122 | -0.069 | 0.201 |
| Â | Model 2 | -0.085 | -0.146 | 0.077 | 0.133 |
| Â | Model 3 | -0.103 | -0.164 | 0.197 | 0.158 |
iPTH (pmol/L) | Model 1 | -0.062 | -0.088 | 0.202 | -0.004 |
| Â | Model 2 | -0.077 | -0.066 | 0.132 | -0.022 |
| Â | Model 3 | -0.096 | -0.097 | 0.215 | 0.045 |
Men ( n = 42) | Â | BP medication users ( n = 24) | BP medication non-users ( n = 18) | ||
| Â | Â | SBP (mmHg) | DBP (mmHg) | SBP (mmHg) | DBP (mmHg) |
25(OH)D3 (nmol/L) | Model 1 | -0.163 | -0.015 | -0.674 ** | -0.579 * |
| Â | Model 2 | -0.207 | -0.088 | -0.619 * | -0.529 * |
| Â | Model 3 | -0.207 | -0.088 | -0.843 ** | -0.785 ** |
iPTH (pmol/L) | Model 1 | 0.127 | 0.185 | 0.010 | -0.194 |
| Â | Model 2 | -0.015 | 0.054 | -0.053 | -0.144 |
| Â | Model 3 | -0.016 | 0.053 | -0.449 | -0.512 * |